Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 3, 2009, Pages 214-220

  Pedersen, Søren ^a   Engelstätter, Renate ^b   Weber, Hans Jochen ^b   Hirsch, Sabine ^b   Barkai, László ^c   Emeryk, Andrej ^d   Weber, Heinrich ^e   Vermeulen, Jan ^a  

^a KOLDING HOSPITAL   (Denmark)

^b Nycomed GmbH   (Germany)

^c Borsod A Z County University Hospital   (Hungary)

^d University of Medicine at Lublin   (Poland)

^e Panorama ^*

Author keywords

Asthma; Children; Ciclesonide; Efficacy; Fluticasone propionate; Hypothalamic pituitary adrenal axis; Inhaled corticosteroids; Safety

Indexed keywords

CICLESONIDE; CREATININE; FLUTICASONE PROPIONATE; HYDROCORTISONE; METHACHOLINE; SALBUTAMOL;

ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY FLOW; HUMAN; HYDROCORTISONE URINE LEVEL; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; THRUSH; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHOCONSTRICTOR AGENTS; CHILD; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROCORTISONE; LUNG; MALE; METHACHOLINE CHLORIDE; PREGNENEDIONES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 67349207839     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2008.12.013     Document Type: Article

References (28)

1. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
2. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Programme. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma 2007. Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf (accessed October 2007).
3. Rabe K.F., Adachi M., Lai C.K., Soriano J.B., Vermeire P.A., Weiss K.B., et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 114 (2004) 40-47
4. Adams R.J., Fuhlbrigge A., Guilbert T., Lozano P., and Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol 110 (2002) 58-64
5. Reed C.E. Inhaled corticosteroids: why do physicians and patients fail to comply with guidelines for managing asthma?. Mayo Clin Proc 79 (2004) 453-455
6. Canonica G.W., Baena-Cagnani C.E., Blaiss M.S., Dahl R., Kaliner M.A., and Valovirta E.J. Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy 62 (2007) 668-674
7. Williams L.K., Pladevall M., Xi H., Peterson E.L., Joseph C., Lafata J.E., et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 114 (2004) 1288-1293
8. Gelfand E.W., Georgitis J.W., Noonan M., and Ruff M.E. Once-daily ciclesonide in children: efficacy and safety in asthma. J Pediatr 148 (2006) 377-383
9. Pedersen S., Garcia Garcia M.L., Manjra A., Theron I., and Engelstätter R. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma. Pediatr Pulmonol 41 (2006) 954-961
10. Boulet L.P., Bateman E.D., Voves R., Muller T., Wolf S., and Engelstätter R. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma. Respir Med 101 (2007) 1677-1686
11. Buhl R., Vinkler I., Magyar P., Gyori Z., Rybacki C., Middle M.V., et al. Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma. Pulm Pharmacol Ther 19 (2006) 404-412
12. Postma D.S., Sevette C., Martinat Y., Schlosser N., Aumann J., and Kafe H. Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. Eur Respir J 17 (2001) 1083-1088
13. Boulet L.P., Drollmann A., Magyar P., Timar M., Knight A., Engelstatter R., et al. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. Respir Med 100 (2006) 785-794
14. Derom E., Van De Velde V., Marissens S., Engelstätter R., Vincken W., and Pauwels R. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5′monophosphate in asthmatic patients. Pulm Pharmacol Ther 18 (2005) 328-336
15. Lee D.K., Fardon T.C., Bates C.E., Haggart K., McFarlane L.C., and Lipworth B.J. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma. Chest 127 (2005) 851-860
16. Lipworth B.J., Kaliner M.A., LaForce C.F., Baker J.W., Kaiser H.B., Amin D., et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 94 (2005) 465-472
17. Szefler S., Rohatagi S., Williams J., Lloyd M., Kundu S., and Banerji D. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma. Chest 128 (2005) 1104-1114
18. Engelstätter R., Escher A., and Hafner D. Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide. Eur Respir J 26 (2005) 255s
19. von Berg A., Engelstätter R., Minic P., Sreckovic M., Garcia Garcia M.L., Latos T., et al. Comparison of the efficacy and safety of ciclesonide 160 microg once daily vs. budesonide 400 microg once daily in children with asthma. Pediatr Allergy Immunol 18 (2007) 391-400
20. Polgar G., and Promadhat U. Pulmonary function testing in children (1971), WB Saunders Company, Philadelphia, PA
21. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., and Townsend M. Measuring quality of life in children with asthma. Qual Life Res 5 (1996) 35-46
22. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., and Townsend M. Measuring quality of life in the parents of children with asthma. Qual Life Res 5 (1996) 27-34
23. Klein G. Recommendations for implementing bronchial provocation tests with pharmacologic substances. German Society of Pneumology-Scientific "Bronchial Provocation Tests" Study Group. Med Klin (Munich) 92 (1997) 458-463
24. Bateman E.D., Linnhof A.E., Homik L., Freudensprung U., Smau L., and Engelstätter R. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma. Pulm Pharmacol Ther 21 (2008) 264-275
25. Currie G.P., Fowler S.J., and Lipworth B.J. Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis. Ann Allergy Asthma Immunol 90 (2003) 194-198
26. LaForce C.F., Pearlman D.S., Ruff M.E., Silvers W.S., Weinstein S.W., Clements D.S., et al. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 85 (2000) 407-415
27. Qaqundah P.Y., Sugerman R.W., Ceruti E., Maspero J.F., Kleha J.F., Scott C.A., et al. Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study. J Pediatr 149 (2006) 663-670
28. Skoner D.P., Maspero J., and Banerji D. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 121 (2008) e1-14